XML 17 R3.htm IDEA: XBRL DOCUMENT v3.25.4
CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Thousands
Jan. 31, 2026
Jan. 31, 2025
Current assets:    
Cash and cash equivalents $ 1,272,877 $ 1,349,380
Marketable securities 6,544,031 6,442,329
Accounts receivable, net of allowances of $18,348 and $22,078 as of January 31, 2026 and 2025, respectively 497,339 495,228
Deferred contract acquisition costs, current 108,856 188,358
Prepaid expenses and other current assets 234,856 200,679
Total current assets 8,657,959 8,675,974
Deferred contract acquisition costs, noncurrent 215,533 123,464
Property and equipment, net 264,525 330,475
Operating lease right-of-use assets 52,423 55,900
Strategic investments 1,578,611 591,481
Goodwill 400,392 307,295
Deferred tax assets 646,640 749,759
Other assets, noncurrent 144,333 154,073
Total assets 11,960,416 10,988,421
Current liabilities:    
Accounts payable 6,268 8,345
Accrued expenses and other current liabilities 581,773 558,562
Deferred revenue, current 1,411,149 1,336,387
Total current liabilities 1,999,190 1,903,294
Deferred revenue, noncurrent 13,195 17,274
Operating lease liabilities, noncurrent 30,710 37,406
Other liabilities, noncurrent 109,063 95,363
Total liabilities 2,152,158 2,053,337
Commitments and contingencies (Note 9)
Stockholders’ equity:    
Common stock, $0.001 par value per share, 2,000,000,000 Class A shares authorized as of January 31, 2026 and 2025; 266,805,638 and 263,113,866 shares issued and outstanding as of January 31, 2026 and 2025, respectively; 300,000,000 Class B shares authorized as of January 31, 2026 and 2025; 28,721,770 and 42,626,998 shares issued and outstanding as of January 31, 2026 and 2025, respectively 295 305
Additional paid-in capital 4,099,753 5,130,271
Accumulated other comprehensive income 8,544 4,990
Retained earnings 5,699,666 3,799,518
Total stockholders’ equity 9,808,258 8,935,084
Total liabilities and stockholders’ equity $ 11,960,416 $ 10,988,421